DNMT3A and B-cell chronic lymphocytic leukemia: Importantly, both Dnmt3aΔ/Δ and Dnmt3a+/− CLL samples showed large-scale promoter hypomethylation strongly suggesting that aberrant promoter hypomethylation may play a role in disease development (26).